Exelixis
The Executive Director, Toxicology leads a team of toxicologists to develop and implement nonclinical safety strategies for small and large molecule programs. This role establishes the vision, strategy, and scientific standards for the Toxicology function to support organizational objectives and portfolio growth. The position involves overseeing study design, regulatory submissions, and cross-functional collaboration to drive integrated development plans.
Headquarters
Alameda, California, United States
Company Size
1001-5000 employees
Founded
1994
Exelixis is an oncology-focused biotech company innovating cancer treatments for life. Find out how we're dedicated to giving more patients hope for the future.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Exelixis.
65% above the average for this role
Exelixis Q4 2025 slides: Strong earnings growth amid oncology franchise expansion
2 days ago
Senior Director, Toxicology (CNS Specialist)
Centessa Pharmaceuticals
Director, Toxicology
Vir Biotechnology
Executive Director, Head of Toxicology
Centessa Pharmaceuticals
Director/Senior Director, Nonclinical Safety
Nimbus Therapeutics
Director, Toxicology
Praxis Precision Medicines, Inc.
Nonclinical Safety and Pathobiology Group Leader
Gilead Sciences